JODIE HARRISON: Open Payments
NPI 1063061950 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,414 in 77 payments from 35 companies in 2025. Trend: 2023 $3,336 · 2024 $2,110 · 2025 $2,414
Food & beverage: $2,138Education: $275
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma Global Development | 2 | $284 |
| Stemline Therapeutics Inc. | 9 | $198 |
| ABBVIE INC. | 6 | $180 |
| Geron Corporation | 4 | $174 |
| Astellas Pharma US Inc | 4 | $165 |
| Janssen Biotech, Inc. | 7 | $164 |
| Eisai Inc. | 4 | $137 |
| SANOFI-AVENTIS U.S. LLC | 1 | $93 |
| Merck Sharp & Dohme LLC | 4 | $93 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
Products named: Padcev, Orserdu, RYTELO, Lenvima, SARCLISA, Xtandi, RYBREVANT, IMBRUVICA.
Industry payments across LA — which companies pay providers there.
